WUXI

wuxibiologics.com · Wuxi, China

WuXi Biologics is a global contract research, development, and manufacturing organization (CRDMO) that provides end-to-end services for biologics, including discovery, cell line development, process development, clinical and commercial manufacturing. It serves pharmaceutical and biotechnology companies worldwide, generating revenue through fee-for-service and long-term outsourcing and manufacturing contracts. The company supports monoclonal antibodies, bispecifics, recombinant proteins, vaccines, and other biologic modalities across the full product lifecycle.

Revenue
$1B+
Employees
5,001+
Founded
2010
Headquarters
Wuxi, China

WUXI customers on Arbolus

Total customers 20 16 current · 4 former
Reviews growth 8 new reviews since May 2026

Customers who reviewed WUXI

Seniority of WUXI customers

The largest group of people who reviewed WUXI holds Director roles (45%), followed by C-Suite (40%) and Manager (15%).

  • Director 45%
  • C-Suite 40%
  • Manager 15%

Customers sample

Generalist Leader C-Suite NPS 10
Strategy Partner C-Suite NPS 10 Undecided
Other Analyst Director NPS 8

Employer names and spend open once the report publishes.

What 20 Arbolus experts think of WUXI

Overall sentiment: Positive

NPS distribution: 28% scored 10, 22% scored 9, 17% scored 8, with a remaining spread from 3 to 7. Renewal intent is positive, with 7 out of 9 responses indicating 'Yes,' 4 'Not Sure,' and 1 'No' (corresponding to an offboarding implementation stage and low NPS). Stickiness is high, as 78% of respondents have used the service for more than 1 year. Key drivers of positive sentiment include long-term platform use, value perception among high spenders, and strong repeat intent in larger pharma firms.

Tell us when the WUXI report publishes.

We'll email you once the full customer report is ready, with employer names, spend and every written answer. No account needed.

Sentiment

25 Net Promoter Score, from 20 scored reviews
  • Promoters 10
  • Passives 5
  • Detractors 5

Written answers and themes publish with the full report.

Renewal intent

Plan to renew 54%
  • Will renew 7
  • Undecided 5
  • Not renewing 1

Plan to renew, by seniority

  • C-Suite 0% 3 answers
  • Director 57% 7 answers
  • Manager 100% 3 answers
  • 8/10 Average score from customers who will renew
  • 7/10 Average score from undecided customers
  • 3/10 Average score from customers not renewing

For people who use WUXI

Do you use WUXI at work?

Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.

  • 20 customers of WUXI have already contributed

Takes a few minutes. Your identity stays anonymous.